ST8Sia II Antibodies

Santa Cruz Biotechnology provides a broad selection of ST8Sia II monoclonal antibodies for research focused on understanding this important sialyltransferase. ST8Sia II monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ST8Sia II, also known as ST8SIA1, plays an essential role in the biosynthesis of polysialic acid, significantly impacting cell adhesion, migration, and neural development. During neurogenesis and synaptic plasticity, ST8Sia II influences critical processes such as learning and memory formation. Research has shown that ST8Sia II activity is closely linked to various neurological disorders and developmental conditions. Understanding ST8Sia II function continues to reveal new insights into brain development and neurological health. Investigating ST8Sia II expression patterns helps illuminate its role in both normal development and disease states. Current research directions explore how ST8Sia II modifications affect neural circuit formation and maintenance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of ST8Sia II and its impact on human health.